Skip to main content
. 2019 Oct 25;43(1):229–239. doi: 10.3892/or.2019.7390

Table I.

Relationship of PSMG3-AS1 expression with clinic pathological features in breast cancer patients.

Variable

Age (years) Tumor size WHO grade



Expression of lnc-PSMG3-AS1 ≤60 >60 ≤5 cm >5 cm I–II III
Low (%) 13 (81.25)   3 (18. 75) 13 (81.25) 3 (18.75) 11 (68.75) 5 (31.25)
High (%) 10 (58.82) 7 (41.18) 15 (88.24) 2 (11.76) 14 (82.35) 3 (17.65)
P-value 0.259 0.656 0.438